|
|
Post by savzak on Jul 3, 2014 9:03:57 GMT -5
They've added an icon to register your e-mail if you want to be notified when Afrezza will be available. This may be a covert way to gauge initial public interest. If so, the partner might even be interested in the number of people who register for the notifications. Accordingly, the more that register the better. Here's the link to the page with the icon for registering:
www.mannkindcorp.com/product-pipeline-diabetes-afrezza-micro-site.htm
|
|
|
|
Post by notamnkdmillionaire on Jul 3, 2014 9:30:07 GMT -5
They've added an icon to register your e-mail if you want to be notified when Afrezza will be available. This may be a covert way to gauge initial public interest. If so, the partner might even be interested in the number of people who register for the notifications. Accordingly, the more that register the better. Here's the link to the page with the icon for registering:
www.mannkindcorp.com/product-pipeline-diabetes-afrezza-micro-site.htm
I highly doubt it's a marketing gimmick to see how many are interested so that the company can show a partner. MNKD already has the surverys etc to know there is a demand for their drug. The big issue is the education of doctors since they will be the ones who need to see the benefits of Afrezza. And if the company is doing as you think they are, then we as shareholders need to be very very worried because that shows this management team is seriously incompetent. |
|
|
|
Post by alethea on Jul 3, 2014 11:04:56 GMT -5
Thanks! I just registered. What do folks think of using Afrezza for Morning Syndrome aka Dawn Effect (where you go to bed and blood sugar is just fine but awaken with it quite high).
My hope is to use Afrezza upon awakening with a bit of food to lower blood sugar quickly versus having to wait 4 or 5 hours for it to come down as I do now.
I would think that if effective, this would create a HUGE population of Type 2's like me DESPERATE to be able to use Afrezza.
|
|
|
|
Post by babaoriley on Jul 3, 2014 18:21:19 GMT -5
Well, I'm sure alethea's happy so many like her post, but can any one provide some guidance?
|
|
|
|
Post by liane on Jul 3, 2014 19:36:20 GMT -5
baba,
If I understand your question correctly...
I initially see Afrezza being used exactly as labelled, but it is not going to take long to go off-label by both the physicians and the patients themselves. The most immediate use will be as a rescue or corrective dose. Next I see it being used earlier in the diabetes protocol, almost totally displacing the oral anti-diabetic meds. I also see some of the pediatric endos going off label and trying it in their patient population even before the studies are in.
Once a drug has been approved by the FDA, it can and will be used off-label.
|
|
